Eli Lilly (LLY) Asset Utilization Ratio (2010 - 2026)
Eli Lilly (LLY) posted Asset Utilization Ratio of 0.63 for Q1 2026, up 10.05% quarter-over-quarter from 0.57 in Q4 2025, and up 8.2% year-on-year from 0.58 in Q1 2025.
Eli Lilly (LLY) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
Eli Lilly (LLY) has reported Asset Utilization Ratio for 18 consecutive years, with 0.63 the latest figure, recorded in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.63, up 8.2% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.63 (up 8.2% YoY), and the FY2025 annual result was 0.68, up 8.02% from the prior year.
- Asset Utilization Ratio was 0.63 for Q1 2026 at Eli Lilly, up from 0.57 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.63 in Q1 2026 and troughed at 0.54 in Q1 2023.
- Average Asset Utilization Ratio over 5 years is 0.58, with a median of 0.57 recorded in 2024.
- Year-over-year, Asset Utilization Ratio grew 12.35% in 2022 and declined 11.94% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.59 in 2022, then slipped by 4.93% to 0.56 in 2023, then grew by 4.28% to 0.58 in 2024, then slipped by 1.8% to 0.57 in 2025, then advanced by 10.05% to 0.63 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.63 in Q1 2026, 0.57 in Q4 2025, and 0.55 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.63 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.48 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.46 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 0.50 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.50 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.41 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.52 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.12 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.63 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.55 |
| Jun 30, 2025 | 0.56 |
| Mar 31, 2025 | 0.58 |
| Dec 31, 2024 | 0.58 |
| Sep 30, 2024 | 0.55 |
| Jun 30, 2024 | 0.57 |
| Mar 31, 2024 | 0.56 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.57 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.54 |
| Dec 31, 2022 | 0.59 |
| Sep 30, 2022 | 0.62 |
| Jun 30, 2022 | 0.62 |
| Mar 31, 2022 | 0.61 |
| Dec 31, 2021 | 0.58 |
| Sep 30, 2021 | 0.58 |
| Jun 30, 2021 | 0.56 |